CFO
EHC icon

Callan Family Office’s Encompass Health EHC Stock Holding History

Callan Family Office’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$451K Sell
4,663
-798
-15% -$81.8K 0.01% 801
2025
Q4 		$580K Buy
+5,461
New +$633K 0.01% 735
2025
Q3 		– Sell
-2,101
Closed -$258K – 884
2025
Q2 		$258K Buy
+2,101
New +$240K 0.01% 813

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Callan Family Office's EHC Position: Q1 2026 in Review

Callan Family Office reduced its Encompass Health (EHC) stake by 15% in Q1 2026, selling an estimated $81.8K and leaving 4,663 shares worth $451K. The position accounts for 0.01% of the portfolio, ranked #801.

Callan Family Office first reported a position in EHC in Q2 2025 and has held it in 3 quarters since. The position peaked at $580K in Q4 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Callan Family Office held 4,663 shares of Encompass Health worth $451K as of Q1 2026.
  • Callan Family Office sold 798 Encompass Health shares in Q1 2026, an estimated $81.8K.
  • Encompass Health made up 0.01% of Callan Family Office's portfolio in Q1 2026, its #801 holding.
  • Callan Family Office first reported a position in Encompass Health in Q2 2025 and has held it in 3 quarters since.
  • Callan Family Office's Encompass Health position peaked at $580K in Q4 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.